Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
NCT ID: NCT01047358
Last Updated: 2015-10-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
206 participants
OBSERVATIONAL
2010-06-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
NCT01155063
A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients
NCT01305239
Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China
NCT01176916
Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients
NCT00174343
Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin
NCT00932165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ajuvant group
adjuvant setting after two to three years of tamoxifen
Aromasin
25 mg table QD
palliative group
palliative setting after progression of disease with anti-estrogen therapy
Aromasin
25 mg table QD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aromasin
25 mg table QD
Aromasin
25 mg table QD
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Soon Chun Hyang University Hospital Cheonan
Cheonan, Chungcheongnam-do, South Korea
Hallym University Sacred Heart Hospital
Anyang-si, Gyeonggi-do, South Korea
Soon Chun Hyang University Bucheon Hospital
Bucheon-si, Gyeonggi-do, South Korea
Myongji Hospital, Kwangdong Unversity College of Medicine
Goyang-si, Gyeonggi-do, South Korea
Wonkwang University School of Medicine and Hospital (WUH)
Iksan -si, Jeollabuk-do, South Korea
Asan Medical Center
Seoul, Korea, South Korea
Seoul National University Hospital (SNUH)
Seoul, Seoul, South Korea
Hwasun Hospital, Chonnam National University
Cheonnam, South Jeolla Province, South Korea
Inje University Busan Paik Hospital
Busan, , South Korea
Yeung Nam University Hospital
Daegu, , South Korea
Seoul National University Bundang Hospital
Gyeonggi-do, , South Korea
Inha University Hospital
Incheon, , South Korea
Cheil General Hospital & Women's Healthcare Center
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
Korea University Anam Hospital
Seoul, , South Korea
Asan Medical Center, University of Ulsan
Seoul, , South Korea
Korea University Medical Center (KUMC) - Korea University Guro Hospital
Seoul, , South Korea
SMG-SNU Boramae Medical Center
Seoul, , South Korea
Ewha Womans University Mokdong Hospital
Seoul, , South Korea
Ajou University Hospital
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A5991089
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.